Antibodies and proteins developed with new and advantageous functions and properties are known as engineering of proteins and antibodies. Protein engineering can be defined as a process of developing valuable proteins and modification of antibodies to increase similarity and is called antibody engineering. Antibody and protein engineering is used in curing inflammatory disorders, as a new treatment of diseases, for protein purification, and in diagnostic procedures. There are two approaches used for designing new antibodies and proteins – directed evolution and rational designing.
Download exclusive Sample of this report:
The market for antibody engineering is changing quickly due to novel technologies. Moreover, protein engineering offers flexibility in engineering, and designing new and desirable antibodies is expected to be the major factor driving the growth of the market. The future holds huge opportunities for this market due to the rising prevalence of diseases such as cancer and increasing health care concerns.
Emerald Bio, ProSci Incorporated, Precision Antibody, Fusion Antibodies, BioXcell, GenTarget Inc, ImaginAb, Covalab, and IBL International are some of the major players in this market.
View exclusive Global strategic Business report :
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Rest of the World